Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.
CD33
acute myeloid leukemia
biomarkers
gemtuzumab ozogamicin
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
11 Sep 2021
11 Sep 2021
Historique:
received:
19
08
2021
revised:
08
09
2021
accepted:
10
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Acute myeloid leukemia (AML) is a complex hematological malignancy characterized by genetic and clinical heterogeneity and high mortality. Despite the recent introduction of novel pharmaceutical agents in hemato-oncology, few advancements have been made in AML for decades. In the last years, the therapeutic options have rapidly changed, with the approval of innovative compounds that provide new opportunities, together with new challenges for clinicians: among them, on 1 September, 2017 the Food and Drug Administration granted approval for Gemtuzumab Ozogamicin (GO) in combination with daunorubicin and cytarabine for the treatment of adult patients affected by newly diagnosed CD33
Identifiants
pubmed: 34572794
pii: cancers13184566
doi: 10.3390/cancers13184566
pmc: PMC8469571
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Blood. 2007 Feb 1;109(3):1061-8
pubmed: 17008544
Leukemia. 2004 Nov;18(11):1914-7
pubmed: 15385942
Expert Opin Biol Ther. 2011 Oct;11(10):1369-80
pubmed: 21810061
Blood Cancer J. 2019 May 21;9(6):51
pubmed: 31113932
Br J Haematol. 1999 Feb;104(2):328-35
pubmed: 10050716
Blood. 2003 Jun 1;101(11):4589-97
pubmed: 12576328
Leuk Lymphoma. 1997 Oct;27(3-4):257-74
pubmed: 9402325
Blood. 2014 Jan 16;123(3):356-65
pubmed: 24300852
Br J Haematol. 2002 Aug;118(2):411-8
pubmed: 12139724
Leukemia. 2008 Dec;22(12):2284-5
pubmed: 18563175
Cancer. 2003 Mar 15;97(6):1481-7
pubmed: 12627513
Br J Haematol. 2010 May;149(3):376-82
pubmed: 20230405
Blood. 2007 May 15;109(10):4168-70
pubmed: 17227830
Haematologica. 2019 Jan;104(1):113-119
pubmed: 30076173
Radiat Res. 2003 Sep;160(3):291-301
pubmed: 12926987
Am J Hematol. 2015 Jun;90(6):515-23
pubmed: 25753065
Ann N Y Acad Sci. 2008 Nov;1143:61-82
pubmed: 19076345
Nat Cancer. 2020 Aug;1(8):826-839
pubmed: 33123685
Biol Blood Marrow Transplant. 2016 Apr;22(4):698-704
pubmed: 26785332
Ann Hematol. 2015 Dec;94(12):1981-9
pubmed: 26410352
Cancers (Basel). 2019 Sep 06;11(9):
pubmed: 31500210
Oncogene. 2007 May 28;26(25):3679-90
pubmed: 17530021
J Adv Pract Oncol. 2019 Jan-Feb;10(1):68-82
pubmed: 31308990
Blood. 2016 Apr 28;127(17):2157-60
pubmed: 26929274
DNA Repair (Amst). 2003 Apr 2;2(4):363-74
pubmed: 12606118
Blood. 2020 Feb 27;135(9):680-688
pubmed: 31932839
Front Oncol. 2020 Feb 13;10:127
pubmed: 32117773
Int J Hematol. 2013 Jun;97(6):703-16
pubmed: 23709007
Blood. 2020 Dec 24;136(26):3041-3050
pubmed: 33367545
Blood. 1999 Aug 1;94(3):1086-99
pubmed: 10419902
Case Rep Hematol. 2020 Feb 12;2020:1378056
pubmed: 32099697
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7164s-7170s
pubmed: 16203817
J Exp Med. 1989 May 1;169(5):1721-31
pubmed: 2469766
Medicine (Baltimore). 2020 Aug 28;99(35):e22064
pubmed: 32871966
Blood. 2017 Mar 23;129(12):1577-1585
pubmed: 28159741
Oncotarget. 2016 Jul 12;7(28):43281-43294
pubmed: 27248327
PLoS One. 2011;6(9):e24265
pubmed: 21915304
Leukemia. 2008 Jun;22(6):1273-4
pubmed: 17989711
Leuk Res. 2006 Jul;30(7):777-83
pubmed: 16730060
BMC Cancer. 2012 Sep 26;12:431
pubmed: 23013471
Eur J Haematol. 2021 Jul;107(1):111-121
pubmed: 33765335
Haematologica. 2021 May 27;:
pubmed: 34047179
Am J Hematol. 2014 Oct;89(10):964-8
pubmed: 24990142
Blood. 2003 Dec 15;102(13):4277-83
pubmed: 12933575
Blood Cancer J. 2014 Jun 13;4:e218
pubmed: 24927407
Hum Mol Genet. 2014 May 15;23(10):2729-36
pubmed: 24381305
Bioconjug Chem. 2002 Jan-Feb;13(1):47-58
pubmed: 11792178
Am J Hematol. 2014 Apr;89(4):399-403
pubmed: 24375467
J Clin Oncol. 2011 Feb 1;29(4):369-77
pubmed: 21172891
J Clin Immunol. 2016 May;36 Suppl 1:100-7
pubmed: 27003914
Blood. 2012 Jun 28;119(26):6198-208
pubmed: 22286199
J Clin Oncol. 2017 Aug 10;35(23):2674-2682
pubmed: 28644774
Int J Hematol. 2019 Oct;110(4):490-499
pubmed: 31286402
Blood. 2001 May 15;97(10):3197-204
pubmed: 11342449
Blood Rev. 2014 Jul;28(4):143-53
pubmed: 24809231
Haematologica. 2016 Jun;101(6):724-31
pubmed: 26921360
J Clin Oncol. 2016 Mar 1;34(7):747-55
pubmed: 26786921
Exp Hematol. 2009 Jun;37(6):755-66
pubmed: 19463775
Haematologica. 2011 Oct;96(10):1548-51
pubmed: 21791474
Am J Hematol. 2012 Jan;87(1):62-5
pubmed: 22072535
Blood. 2020 Feb 20;135(8):542-546
pubmed: 31880804
Blood. 2005 Feb 1;105(3):1295-302
pubmed: 15454492
Leuk Res. 2018 Nov;74:68-74
pubmed: 30300823
Expert Opin Biol Ther. 2014 Aug;14(8):1185-95
pubmed: 24865510
J Clin Oncol. 2021 Oct 1;39(28):3149-3160
pubmed: 34048275
Blood Cancer J. 2020 Mar 4;10(3):29
pubmed: 32132522
Clin Cancer Res. 2001 Jun;7(6):1490-6
pubmed: 11410481
J Clin Oncol. 2013 Nov 1;31(31):3889-97
pubmed: 24062400
BMC Med. 2016 May 05;14:73
pubmed: 27151159
J Clin Oncol. 2011 Mar 20;29(9):1190-7
pubmed: 21282535
Drugs. 2001;61(9):1317-22; discussion 1323-4
pubmed: 11511025
Blood Adv. 2019 Jan 8;3(1):96-104
pubmed: 30622147
Cancer Res. 2005 May 1;65(9):3671-81
pubmed: 15867362
Front Biosci (Landmark Ed). 2013 Jun 01;18:1311-34
pubmed: 23747885
Ann Hematol. 2017 Mar;96(3):363-371
pubmed: 28011984
Br J Haematol. 1997 Oct;99(1):76-83
pubmed: 9359506
Clin Cancer Res. 2011 Oct 15;17(20):6389-97
pubmed: 22003066
J Clin Oncol. 2012 Nov 10;30(32):3924-31
pubmed: 22851554
Biomol Ther (Seoul). 2015 Nov;23(6):493-509
pubmed: 26535074
Future Oncol. 2021 Jan;17(3):263-277
pubmed: 33356566
Clin Cancer Res. 2013 Mar 15;19(6):1620-7
pubmed: 23444229
Blood. 2005 Aug 15;106(4):1183-8
pubmed: 15886328
Haematologica. 2004 Jan;89(1):34-41
pubmed: 14754604
Anticancer Res. 2014 Oct;34(10):5487-94
pubmed: 25275045
Leuk Res. 2010 Jul;34(7):e152-3
pubmed: 20061019
J Neurosci. 2013 Aug 14;33(33):13320-5
pubmed: 23946390
Leukemia. 2002 May;16(5):813-9
pubmed: 11986941
Leukemia. 2003 Jan;17(1):76-82
pubmed: 12529663
J Clin Oncol. 2017 Jan 10;35(2):185-193
pubmed: 28056203
Biol Blood Marrow Transplant. 2020 May;26(5):884-892
pubmed: 31891815
Oncogene. 2003 Dec 11;22(57):9107-20
pubmed: 14647446
Blood. 2012 Apr 19;119(16):3705-11
pubmed: 22378848
Cancer. 2005 Oct 1;104(7):1442-52
pubmed: 16116598
Mutat Res. 1990 Nov;245(3):171-5
pubmed: 1700294
Cancer. 2013 Nov 15;119(22):4036-43
pubmed: 24006085
J Clin Oncol. 2013 Nov 10;31(32):4123-31
pubmed: 24062403
Am J Hematol. 2018 May;93(5):655-663
pubmed: 29396857
Blood. 2003 Aug 15;102(4):1466-73
pubmed: 12689934
Leuk Res. 1984;8(4):521-34
pubmed: 6590930
Bone Marrow Transplant. 2021 Jun;56(6):1474-1477
pubmed: 33564120
Clin Cancer Res. 2019 Aug 15;25(16):5038-5048
pubmed: 31182436
Eur J Immunol. 2005 Jan;35(1):243-51
pubmed: 15597323
Exp Hematol. 2003 May;31(5):363-71
pubmed: 12763134
Blood. 2008 Aug 15;112(4):1510-4
pubmed: 18550848
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Blood. 2018 Jul 12;132(2):187-196
pubmed: 29692343
Leukemia. 2017 May;31(5):1059-1068
pubmed: 27795558
Blood. 2003 May 15;101(10):3868-71
pubmed: 12543868
Leukemia. 2011 Aug;25(8):1239-48
pubmed: 21566656
Oncotarget. 2014 Feb 28;5(4):916-32
pubmed: 24659740
Lancet. 2012 Apr 21;379(9825):1508-16
pubmed: 22482940
Clin Cancer Res. 2016 Apr 15;22(8):1951-7
pubmed: 26644412
Clin Lymphoma Myeloma Leuk. 2020 Dec;20(12):791-796
pubmed: 32741743
J Clin Oncol. 2016 Mar 20;34(9):972-9
pubmed: 26811524
Br J Haematol. 2010 Mar;148(5):768-76
pubmed: 19995399
Haematologica. 2019 Jan;104(1):120-127
pubmed: 30093401
J Leukoc Biol. 2006 Jan;79(1):46-58
pubmed: 16380601
Ther Adv Med Oncol. 2020 May 27;12:1758835920927635
pubmed: 32636939
Oncotarget. 2014 Aug 15;5(15):6280-8
pubmed: 25026287
Nature. 2016 Dec 15;540(7633):433-437
pubmed: 27926740
Bone Marrow Transplant. 2020 Feb;55(2):452-460
pubmed: 31554931
Expert Opin Biol Ther. 2011 Feb;11(2):225-34
pubmed: 21142804
Clin Cancer Res. 2007 Dec 1;13(23):7059-66
pubmed: 18056183
JCO Precis Oncol. 2019 May 23;3:
pubmed: 32914031
J Clin Oncol. 2020 Feb 20;38(6):623-632
pubmed: 31851556
Biol Blood Marrow Transplant. 2012 Feb;18(2):324-9
pubmed: 22079471
Lancet Oncol. 2014 Aug;15(9):986-96
pubmed: 25008258
Ann Hematol. 2012 Dec;91(12):1871-7
pubmed: 22820971
J Hematol Oncol. 2018 Jan 12;11(1):8
pubmed: 29329556
Pediatr Blood Cancer. 2020 Jun;67(6):e28305
pubmed: 32307866
Glycobiology. 2011 Jun;21(6):757-70
pubmed: 21278227
Leuk Lymphoma. 2012 Jul;53(7):1399-405
pubmed: 22242821
Blood. 2001 Aug 15;98(4):988-94
pubmed: 11493443
Minerva Med. 2020 Oct;111(5):395-410
pubmed: 32955828
Leuk Lymphoma. 2018 Sep;59(9):2250-2253
pubmed: 29320902
Nat Biotechnol. 2009 Aug;27(8):767-71
pubmed: 19620983